Serum amyloid A3 (Saa3) is also identified as new biomarker of mouse PDGFRα+ CAFs in PDAC, as PDGFRα+Saa3+ CAFs could facilitate tumor growth while PDGFRα+Saa3− CAFs impairing tumor proliferation [53]. The gene discussed is PDGFRA; the disease is neoplasm.